A strategic neurological research agenda for Europe: Towards clinically relevant and patient-centred neurological research priorities.
Europe
neurological disorders
research agenda
research gaps
research priorities
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
revised:
15
11
2023
received:
10
08
2023
accepted:
16
11
2023
medline:
12
12
2023
pubmed:
12
12
2023
entrez:
12
12
2023
Statut:
aheadofprint
Résumé
Neurological disorders constitute a significant portion of the global disease burden, affecting >30% of the world's population. This prevalence poses a substantial threat to global health in the foreseeable future. A lack of awareness regarding this high burden of neurological diseases has led to their underrecognition, underappreciation, and insufficient funding. Establishing a strategic and comprehensive research agenda for brain-related studies is a crucial step towards aligning research objectives among all pertinent stakeholders and fostering greater societal awareness. A scoping literature review was undertaken by a working group from the European Academy of Neurology (EAN) to identify any existing research agendas relevant to neurology. Additionally, a specialized survey was conducted among all EAN scientific panels, including neurologists and patients, inquiring about their perspectives on the current research priorities and gaps in neurology. The review revealed the absence of a unified, overarching brain research agenda. Existing research agendas predominantly focus on specialized topics within neurology, resulting in an imbalance in the number of agendas across subspecialties. The survey indicated a prioritization of neurological disorders and research gaps. Building upon the findings from the review and survey, key components for a strategic and comprehensive neurological research agenda in Europe were delineated. This research agenda serves as a valuable prioritization tool for neuroscientific researchers, as well as for clinicians, donors, and funding agencies in the field of neurology. It offers essential guidance for creating a roadmap for research and clinical advancement, ultimately leading to heightened awareness and reduced burden of neurological disorders.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Neurological disorders constitute a significant portion of the global disease burden, affecting >30% of the world's population. This prevalence poses a substantial threat to global health in the foreseeable future. A lack of awareness regarding this high burden of neurological diseases has led to their underrecognition, underappreciation, and insufficient funding. Establishing a strategic and comprehensive research agenda for brain-related studies is a crucial step towards aligning research objectives among all pertinent stakeholders and fostering greater societal awareness.
METHODS
METHODS
A scoping literature review was undertaken by a working group from the European Academy of Neurology (EAN) to identify any existing research agendas relevant to neurology. Additionally, a specialized survey was conducted among all EAN scientific panels, including neurologists and patients, inquiring about their perspectives on the current research priorities and gaps in neurology.
RESULTS
RESULTS
The review revealed the absence of a unified, overarching brain research agenda. Existing research agendas predominantly focus on specialized topics within neurology, resulting in an imbalance in the number of agendas across subspecialties. The survey indicated a prioritization of neurological disorders and research gaps.
CONCLUSIONS
CONCLUSIONS
Building upon the findings from the review and survey, key components for a strategic and comprehensive neurological research agenda in Europe were delineated. This research agenda serves as a valuable prioritization tool for neuroscientific researchers, as well as for clinicians, donors, and funding agencies in the field of neurology. It offers essential guidance for creating a roadmap for research and clinical advancement, ultimately leading to heightened awareness and reduced burden of neurological disorders.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406-2415. doi:10.1038/s41591-022-02001-z
Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255-265. doi:10.1016/S1474-4422(19)30411-9
Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718-779. doi:10.1016/j.euroneuro.2011.08.008
The Economist Impact. The value of action: mitigating the global impact of neurological disorders. 2022.
Chinthapilli K. Brain disorders cost the most overall but attract the least research funding. BMJ. 2013;347:f4766.
World Health Assembly. Intersectoral global action plan on epilepsy and other neurological disorders. 2021.
Gudowsky N. Limits and benefits of participatory agenda setting for research and innovation. Eur J Futures Res. 2021;9(1):8. doi:10.1186/s40309-021-00177-0
Crowe S, Fenton M, Hall M, Cowan K, Chalmers I. Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch. Res Involv Engagem. 2015;1(1):2. doi:10.1186/s40900-015-0003-x
The Shared European Brain Research Agenda. The European brain research area. https://www.ebra.eu/sebra/. Accessed June 1, 2023.
Bassetti CLA, Endres M, Sander A, et al. The European Academy of Neurology Brain Health Strategy: one brain, one life, one approach. Eur J Neurol. 2022;29(9):2559-2566. doi:10.1111/ene.15391
Deuschl G, Beghi E, Fazekas F, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5(10):e551-e567. doi:10.1016/S2468-2667(20)30190-0
Field AP. Kendall's coefficient of concordance. In: Balakrishnan N, Colton T, Everitt B, Piegorsch W, Ruggeri F, & Teugels J, eds. Wiley StatsRef: Statistics Reference Online. John Wiley & Sons, Ltd; 2014. doi:10.1002/9781118445112.stat06537
Bassetti CL, Ferini-Strambi L, Brown S, et al. Neurology and psychiatry: waking up to opportunities of sleep.: State of the art and clinical/research priorities for the next decade. Eur J Neurol. 2015;22(10):1337-1354. doi:10.1111/ene.12781
Turner GM, Backman R, McMullan C, Mathers J, Marshall T, Calvert M. Establishing research priorities relating to the long-term impact of TIA and minor stroke through stakeholder-centred consensus. Res Involv Engagem. 2018;4:2. doi:10.1186/s40900-018-0089-z
Norrving B, Barrick J, Davalos A, et al. Action plan for stroke in Europe 2018-2030. Eur Stroke J. 2018;3(4):309-336. doi:10.1177/2396987318808719
Stinear CM, Lang CE, Zeiler S, Byblow WD. Advances and challenges in stroke rehabilitation. Lancet Neurol. 2020;19(4):348-360. doi:10.1016/S1474-4422(19)30415-6
Hill G, Regan S, Francis R, et al. Research priorities to improve stroke outcomes. Lancet Neurol. 2022;21(4):312-313. doi:10.1016/S1474-4422(22)00044-8
Motl RW, Mowry EM, Ehde DM, et al. Wellness and multiple sclerosis: the National MS Society establishes a Wellness Research Working Group and research priorities. Mult Scler. 2018;24(3):262-267. doi:10.1177/1352458516687404
Sumowski JF, Benedict R, Enzinger C, et al. Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology. 2018;90(6):278-288. doi:10.1212/WNL.0000000000004977
Bebo BF, Allegretta M, Landsman D, et al. Pathways to cures for multiple sclerosis: a research roadmap. Mult Scler. 2022;28(3):331-345. doi:10.1177/13524585221075990
MacDuffie KE, Grubbs L, Best T, et al. Stigma and functional neurological disorder: a research agenda targeting the clinical encounter. CNS Spectr. 2020;1-6. doi:10.1017/S1092852920002084
Gilbert LA, Fehlings DL, Gross P, et al. Top 10 research themes for dystonia in cerebral palsy: a community-driven research agenda. Neurology. 2022;99(6):237-245. doi:10.1212/WNL.0000000000200911
Schiess N, Cataldi R, Okun MS, et al. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority. JAMA Neurol. 2022;79(9):929-936. doi:10.1001/jamaneurol.2022.1783
De Miranda B, Goldman S, Miller G, Greenamyre J, Dorsey E. Preventing Parkinson's disease: an environmental agenda. J Parkinsons Dis. 2021;12:1-24. doi:10.3233/JPD-212922
Dams-O'Connor K, Bellgowan PSF, Corriveau R, et al. Alzheimer's disease-related dementias summit 2019: National Research Priorities for the investigation of traumatic brain injury as a risk factor for Alzheimer's disease and related dementias. J Neurotrauma. 2021;38(23):3186-3194. doi:10.1089/neu.2021.0216
Martin A, O'Connor S, Jackson C. A scoping review of gaps and priorities in dementia care in Europe. Dementia. 2020;19(7):2135-2151. doi:10.1177/1471301218816250
Singh A, Woelfle R, Chepesiuk R, et al. Canadian epilepsy priority-setting partnership: toward a new national research agenda. Epilepsy Behav. 2022;130:108673. doi:10.1016/j.yebeh.2022.108673
Hocker S, Shah S, Vespa P, et al. The future of neurocritical care research: proceedings and recommendations from the Fifth Neurocritical Care Research Network Conference. Neurocrit Care. 2020;32(1):311-316. doi:10.1007/s12028-019-00767-8
Gatchel RJ, Reuben DB, Dagenais S, et al. Research agenda for the prevention of pain and its impact: report of the work group on the prevention of acute and chronic pain of the Federal Pain Research Strategy. J Pain. 2018;19(8):837-851. doi:10.1016/j.jpain.2018.02.015
British Paediatric Neurology Association. Childhood neurological conditions | James Lind Alliance. 2022. Accessed February 8, 2023. https://www.jla.nihr.ac.uk/priority-setting-partnerships/childhood-neurological-conditions/
Hutchison JS, Emery C, Gagnon I, et al. The Canadian Traumatic Brain Injury Research Consortium: epitomizing collaborative research in Canada. J Neurotrauma. 2018;35(16):1858-1863. doi:10.1089/neu.2018.5871
Perez DL, Nicholson TR, Asadi-Pooya AA, et al. Neuroimaging in functional neurological disorder: state of the field and research agenda. Neuroimage Clin. 2021;30:102623. doi:10.1016/j.nicl.2021.102623
Ali M, Soroli E, Jesus LMT, et al. An aphasia research agenda - a consensus statement from the collaboration of aphasia trialists. Aphasiology. 2022;36(4):555-574. doi:10.1080/02687038.2021.1957081
Tyson S, Stanley K, Gronlund TA, et al. Research priorities for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): the results of a James Lind alliance priority setting exercise. Fatigue. 2022;10(4):200-211. doi:10.1080/21641846.2022.2124775
Sex, gender, and the cost of neurological disorders, towards an inclusive research agenda. Lancet Neurol. 2023;22:367.
Rukovets O. A scoping review: what effects do climate change and air pollution have on neurologic disorders? Neurol Today. 2022;22(24):7. doi:10.1097/01.nt.0000905788.76255.4d